9:22 AM
Leo Group India
| ||
| Bristol-Myers to Acquire Amylin for $5.3 Billion Businessweek Bristol-Myers (BMY) Squibb Co., which failed to get U.S. approval for a new diabetes treatment in January, will pay $5.3 billion for Amylin Pharmaceuticals Inc. (AMLN), the maker of two drugs on the market for the disease. See all stories on this topic » | ||
| ||
| PHARMA-PATENT 2 LASTBCM5 IBNLive.com Leading global generic pharmaceutical manufacturers Leading global generic pharmaceutical manufacturers have been proactive in forging strategic alliances with branded pharmaceutical companies for marketing rights and exclusivity in producing generic ... See all stories on this topic » | ||
| Bristol-Myers to buy Amylin for about $5.3 billion Deccan Herald Bristol-Myers said it had also reached a follow-on deal with UK-based AstraZeneca Plc on Frida to collaborate on developing Amylin's products once the buyout is completed, expanding upon an existing partnership between the two pharmaceutical makers in ... See all stories on this topic » | ||
| Lilly Statement on Affordable Care Act Ruling by… Pharmaceutical Processing INDIANAPOLIS , June 28, 2012 /PRNewswire/ -- Following is a statement from John C. Lechleiter , Ph.D., chairman, president, and chief executive officer of Eli Lilly and Company , regarding today's U.S. Supreme Court ruling to uphold the Affordable Care ... See all stories on this topic » | ||
| Drug patents expiry to give generic pharma market shot in arm Deccan Chronicle The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs, and the judicious cost containment efforts of governments and healthcare service providers ... See all stories on this topic » | ||
| 'Essential medicines out of reach for most people' The Hindu The National production of drugs and pharmaceuticals in India has crossed rupees one lakh crore but 50 to 65 per cent of the population have no regular access to essential medicines according to a WHO estimate, alleged All India Drugs Control Officers' ... See all stories on this topic » | ||
| Drugmaker JHP to expand Rochester facility, hire scientists Detroit Free Press JHP Pharmaceuticals, with a 25-person headquarters in Parsippany, N.J., employs an estimated 340 people in Michigan and plans to hire another 15 scientists, according to vice president of quality operations Rick Whitfield. The company makes sterile, ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment